Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Rogier Hintzen, Michelle Mellion et al.|The Lancet Neurology|2019Cited by 185
Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune CellsPhilip E. Brandish, Mark Zielstorff, Mangeng Cheng et al.|Bioconjugate Chemistry|2018Cited by 58
Isovitexin Inhibits Ginkgolic Acids-Induced Inflammation Through Downregulating SHP2 ActivationYiwei Zhang, Xianying Fang|Frontiers in Pharmacology|2021Cited by 25